Home Compliance Applying Escobar, Court Rejects Comparative Effectiveness and “Fraud on the Formulary” Claims ComplianceExpert OpinionNews Applying Escobar, Court Rejects Comparative Effectiveness and “Fraud on the Formulary” Claims July 6, 2017 7 Share FacebookLinkedinTwitter You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance Relator Alleged Violation of Statutes But Didn’t Adequately Plead False Certification Compliance Keeping the Lodestar Local — Mississippi Court Refuses to Apply D.C. Rates for FCA Fee Award Compliance Fraud-on-the-FDA is Not False for the FCA